When mapping out a family medical history, most men focus on conditions traditionally associated with male health or common chronic illnesses. A lineage marked by type 2 diabetes, cardiovascular disease, hypertension, or colorectal cancer routinely prompts individuals to take preventative action and schedule screenings with their physicians. However, when a family tree reveals recurring cases of breast cancer, men frequently brush off the information, operating under the long-held assumption that the disease is exclusive to women and clinically irrelevant to their own personal health.
Because breast cancer public awareness initiatives, advocacy campaigns, and routine screening programs focus almost entirely on women, men often believe that carrying an inherited predisposition to the disease is an anatomical impossibility or a non-issue. Oncologists and genetic specialists emphasize that this gendered approach to family health history represents a significant blind spot in male preventive care.
"Men think of BRCA1 and BRCA2 and they think of typically female diseases, so they assume it doesn’t matter to them," says Jane Lowe Meisel, MD, a medical oncologist at Emory Winship Cancer Institute in Atlanta and an American Society of Clinical Oncology expert in breast cancer. "But men can have those genes too."
The biological reality is that inherited gene changes, such as mutations in the BRCA1 and BRCA2 genes, do not select for gender when passed down through generations. While these mutations are widely known for substantially increasing a woman’s lifetime risk of developing breast and ovarian cancers, they simultaneously raise a man’s risk for developing male breast cancer and prostate cancer. Furthermore, the presence of these genetic variations elevates the risk of pancreatic cancer across both sexes. Understanding the complete scope of a family’s cancer history is therefore essential for men who wish to manage their long-term health proactively.
What to look for in your family
Evaluating a family’s health history requires distinguishing between isolated, sporadic occurrences of cancer and multi-generational patterns that suggest an underlying genetic mutation. Breast cancer is exceptionally prevalent among women in the general population; current clinical statistics indicate that approximately one out of every eight women in the United States will develop breast cancer over the course of her lifetime. Because the baseline frequency of the disease in women is so high, many families will have a female relative affected by breast cancer purely by chance rather than through an inherited genetic syndrome.
Dr. Meisel notes that an isolated diagnosis in a distant female relative should not automatically cause alarm for male family members. "Breast cancer in women is so common, and the vast majority of men related to those women won’t have to deal with breast cancer," she explains.
The clinical concern increases when a family history demonstrates features of what oncologists classify as a strong family history of hereditary cancer. According to Giacomo Montagna, MD, MPH, a breast surgeon and co-director of the Rare Breast Cancer Program at Memorial Sloan Kettering Cancer Center, identifying specific red flags within a family tree can help determine whether genetic testing is warranted.
Strong familial patterns typically involve multiple close relatives across generations on either the maternal or paternal side who have been diagnosed with breast, ovarian, prostate, or pancreatic cancers. Particular attention is given to families where diagnoses occurred at unusually young ages, where an individual developed multiple primary cancers, or where male breast cancer has previously occurred in the bloodline.
Dive deep into what’s going on
When a strong pattern of cancer exists within a bloodline, patients and clinicians face an essential medical question: Could an inherited mutation in BRCA1, BRCA2, or one of the more than 20 other susceptibility genes identified by researchers be driving the elevated cancer rate within the family?
Establishing an accurate genetic profile has become increasingly simple in clinical practice. Assessing inherited cancer risk requires only a standard blood test or, in many cases, a simple saliva sample. "If your test is positive, you were born with a genetic predisposition to develop cancer," says Dr. Montagna.
For individuals who already have a relative—whether male or female—who has tested positive for a BRCA mutation, undergoing personalized genetic testing remains vital. Inheriting a pathogenic variant is not guaranteed simply because a family member carries it. Genetic transmission follows a classic 50-50 inheritance pattern: a parent carrying a BRCA mutation has a 50 percent chance of passing that specific genetic change to each child they have. Consequently, a person shares a 50 percent probability of testing positive if one of their biological siblings or parents carries the mutation.
This equal distribution of risk remains constant regardless of sex. "There’s a misconception that the BRCA gene only affects women, but it’s not true at all," Dr. Montagna explains. "Males have the exact same risk of acquiring the mutation from their parents."
To understand how these genetic changes impact long-term health, it helps to examine their baseline biological function. Every person is born with functional BRCA1 and BRCA2 genes in their cells. In their normal state, these genes produce proteins responsible for identifying and repairing double-strand DNA mistakes that routinely occur during normal cell division and biological processes.
"They are DNA repair mechanisms," says Dr. Montagna. While human DNA can contain harmless genetic variations that do not alter cellular function, specific pathogenic mutations stop these crucial DNA repair mechanisms from functioning correctly. When these repair processes are disrupted, genetic errors accumulate unchecked over time. "At the end of the day, a cancer cell is one with a lot of DNA mistakes," Dr. Montagna notes.
While both genes operate as critical cellular safeguards, BRCA1 and BRCA2 are distinct structures, and mutations in each carry different statistical risks for male health. In the general male population without an inherited genetic predisposition, male breast cancer is a rare occurrence, with approximately 1 in 1,000 men developing the disease during their lifetime. However, the presence of a pathogenic mutation alters these odds considerably.
"If you have the BRCA1 mutation, the risk is about 1/100, or 1%," Dr. Montagna states. "And if you carry the BRCA2 change, the risk goes up to 7%. It really significantly increases."
You have a BRCA mutation—now what?
Receiving a positive result for a BRCA mutation can feel overwhelming, but medical specialists stress that a genetic predisposition is not a definitive cancer diagnosis. Carrying a mutation simply means an individual possesses a higher statistical risk than the general population, providing an opportunity to implement targeted surveillance strategies and catch potential changes as early as possible.
A primary challenge in male breast cancer management is the absence of routine screening programs for men. While adult women undergo routine mammography screenings, men do not receive population-based imaging. As a result, men who develop breast cancer are frequently diagnosed at significantly later stages of disease progression.
"Men aren’t screened for breast cancer, so they tend to present with more advanced cancer," Dr. Montagna explains. "They’ll say they had a lump for years by the time they see a breast cancer specialist, so the tumors are more advanced."
Recognizing potential symptoms early is critical for improving diagnostic timelines. Due to male breast anatomy, initial signs often appear in a specific location. "The most common symptom is a painless mass behind your nipple," says Dr. Montagna. "Most breast cancer in men is behind the nipple because that’s where the milk-duct structures are." In addition to a firm, painless retroareolar lump, men should watch for other localized changes, such as fluid discharge or nipple retraction, where the nipple turns inward.
Because formal screening mammograms are not routinely performed on asymptomatic men, self-awareness serves as the frontline defense. "Prevention is mostly monthly self-awareness exams," says Dr. Meisel. "Know what your chest feels like so you can bring up changes to your doctor."
Furthermore, because inherited BRCA mutations also elevate the risks for prostate and pancreatic cancers, men who test positive should work closely with their healthcare providers to establish comprehensive screening plans for those conditions. "All men should be aware of their body," Dr. Meisel emphasizes. "Something odd might be nothing, but if it is something, you’ll be glad you caught it early."
For individuals navigating genetic test results, scheduling a formal consultation with a genetic counselor can provide critical support. Genetic counselors specialize in translating complex genetic laboratory findings, helping patients understand specific health risks, and guiding families on how to communicate inheritable risk factors to relatives, siblings, and future generations.
